Application of molecular biology to radiobiology and radiation oncology has improved our understanding of cellular radiation responses of both tumor and normal cells. Consequently, mechanistic insights resulting from molecular radiation biology/oncology research will thus provide tools to develop new strategies of individualized therapy and molecular targeting in modern radiation oncology to further improve tumor responses and reduce normal tissue reactions.

Cutting-edge results to these aspects are discussed in the Wolfsberg Meeting Series on Molecular Radiation Biology/Oncology , which was started in 1997 and is organized since 2005 in association with ESTRO, the European Society of Radiation Therapy and Oncology. The Wolfsberg Meeting Series brings together both experienced as well as young basic and clinical scientists of the disciplines Molecular and Cell Biology, Tumor and Normal Tissue Biology, Radiobiology and Radiation Oncology to discuss the newest developments in molecular radiation biology/oncology, which most likely will have tremendous impact on the development of future treatment strategies in radiation oncology.

As translation of basic research findings into clinical application needs an intensified dialogue between basic and clinical scientists, the structure and spirit of the Wolfsberg Meeting Series creates the informal atmosphere and platform to discuss specific questions without time pressure usually encountered at bigger conferences.